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Background: To report two cases of atypical vitelliform macular dystrophy misdiagnosed as chronic central serous
chorioretinopathy.
Case presentation: Two patients with incidentally discovered abnormalities of the retina without specific
symptoms were referred to our hospital for consultation. Bilateral macula atrophic lesions were observed and
optical coherence tomography revealed serous retinal detachment in the macula. Fluorescein angiography showed
multiple leakages around the central hypofluorescent area and indocyanine green angiography showed partially
dilated choroidal vessels. Fundus autofluorescence (FAF) showed a decreasing pattern of autofluorescence in the
subretinal fluid area, and increasing autofluorescence at the border of the serous retinal detachment. Both patients
were diagnosed with chronic central serous chorioretinopathy. Photodynamic therapy and intravitreal bevacizumab
injection were administered for engorged choroidal vessels during follow-up, but neither patient showed
improvement in symptoms or ophthalmologic findings. Based on re-evaluation by fundus photography, optical
coherence tomography, fluorescein angiography, and comparison of the results of FAF with the first visit, vitelliform
macular dystrophy was suspected and a definite diagnosis was made by electrooculography and genetic testing.
Conclusion: In patients with continuous serous retinal detachment without response to photodynamic therapy or
intravitreal bevacizumab injection, careful fundus exam and FAF can be used to diagnose atypical vitelliform
macular dystrophy.Background
Vitelliform macular dystrophy (VMD) is an autosomal-
dominant disease that can cause a gene mutation of
bestrophin-1 (Best-1). This gene codes for a Ca2+-sensi-
tive Cl− channel protein located on the basolateral mem-
brane of the retinal pigment epithelial cells [1-5]. There
are several disease-causing mutations and the pheno-
typic appearance varies with the stage of the disease
[6,7]. Previously, it was believed that congenital Best dis-
ease, adult-onset VMD, and autosomal dominant
vitreoretinochoroidopathy were different disease entities.
The identification of mutations in the Best1 gene, how-
ever, altered this notion and revealed that most* Correspondence: syyu@khu.ac.kr
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reproduction in any medium, provided the orindividuals with these phenotypes had mutations in the
same genes [8,9].
VMD can develop in various age groups, is usually bi-
lateral, and induces a severe decrease of vision in the
early stage, but in some cases visual acuity loss pro-
gresses insidiously. The typical fundus finings of VMD
include a solitary, round or oval, slightly elevated,
yellowish, subretinal lesion of the fovea [10,11]. Optical
coherence tomography (OCT) shows thick hyper-
reflective structures in the retinal pigmented epithelium
(RPE) layer or between the RPE layer and photoreceptor
layer, and serous retinal detachment [12]. Fluorescence
angiography reveals early blockages and late intense
hyperfluorescent circles with hypofluorescent central
zones. Fundus autofluorescence (FAF) findings vary, but
usually show hyperautofluorescence at the lesion site
[13]. A decrease in the Arden ratio in the electrooculo-
gram (EOG) is a pathognomic characteristic [14].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Case 1. Fundus photographs and optical cohenrece tomography (OCT) at initial presentation. A,B, Fundus photographs showed
atrophic lesion in central area, both eyes. C,D, OCT findings of both eyes showed serous retinal detachment over a large area.
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ophthalmologic examinations annually or twice annually
to determine the occurrence of complications or
comorbidities are necessary. Patients diagnosed with
VMD should be frequently evaluated with an Amslers
grid to elucidate changes or decreases in vision. As this
is a genetic disorder, family members should also be
examined. Some case reports indicate that photo-
dynamic therapy and antivascular endothelial growth
factor are effective against choroidal neovascularization,
but to date there are no clinically established treat-
ments available [15,16].
Here we report two cases of atypical VMD in patients
who were misdiagnosed with chronic central serous
chorioretinopathy (CSC) and did not respond to either




A 30-year-old man presented with incidentally discov-
ered slightly decreased visual acuity in both eyes. He hadno history of diabetes, hypertension, or any other med-
ical history, and was not on any medications. The best-
corrected visual acuity was 20/25 in the right eye and
20/22 in the left eye. Anterior segment examination
showed no abnormal findings, but fundus examination
and OCT revealed bilateral atrophic foveal lesions and
extensive serous retinal detachment in the posterior pole
of the retina (Figure 1). Fluorescein angiography showed
bilateral hypofluorescence in the fovea, surrounding
hyperfluorescence, and multiple fluorescent leakages.
Indocyanine green angiography revealed slightly dilated
choroidal vessels near the foveal region. FAF showed
hypoautofluorescence in the central area and hyperauto-
fluorescence at the border of the serous retinal detach-
ment (Figure 2). Serologic examination showed no
significant findings, and electroretinography revealed a
normal waveform and amplitude in both eyes. The pa-
tient was diagnosed with chronic CSC, and at 10 months
of follow-up, fundus examination and OCT showed the
continued presence of subretinal fluid and no improve-
ment in visual acuity. Photodynamic therapy was con-
ducted in the areas of the hyperlucent choroidal vessels
Figure 2 A, Fluoresecein angiography findings of right eye revealed multiple leakages around the central hypofluorescence area. B,
Indocyanine green angiography showed dilated choroidal vessel. C,D, Fundus autofluorescence findings of both eyes revealed central
hypoautofluorescence and ring-like hyperautofluorescence at margin of serous retinal detachment.
Lee et al. BMC Ophthalmology 2012, 12:25 Page 3 of 8
http://www.biomedcentral.com/1471-2415/12/25that were identified by indocyanine green angiography,
but there was no improvement in symptoms or clinical
presentation. At 15 months after the first visit, intravi-
treal antivascular endothelial growth factor was injected
but again the patient showed no improvement. At 18
months, laser photocoagulation was applied for a sus-
pected leaking point based on fluorescein angiography.
Progressive decreases in visual acuity and serous retinal
detachment continued through the long-term follow-up.
Case 2
A 51-year-old man with no specific symptoms was re-
ferred to us for incidentally found macula abnormalities
during a regular checkup. He had no diabetes, hyperten-
sion, underlying diseases, or family history. Bilateral
best-corrected visual acuity was 20/22 with no clinical
findings in the anterior segment, but fundus examin-
ation revealed atrophic lesions in the bilateral macula.
Optical coherence tomography revealed a wide range of
serous retinal detachments in both eyes (Figure 3).
Fluorescein angiography showed both hypofluorescence
of foveal lesions and ring-like hyperfluorescence in sur-
rounding areas. Indocyanine green angiography showed
engorgement of the choroidal vessels. FAF showed
decreased autofluorescence in the central area andincreased autofluorescence at the border of the serous
retinal detachment (Figure 4). Bilateral chronic CSC was
suspected and photodynamic therapy was applied during
follow-up to the areas of dilated choroidal vessels based
on indocyanine green angiography, but the serous retinal
detachment did not improve.
These two cases of suspected chronic CSC showed
continuous serous retinal detachment even after the
photodynamic therapy over 3 years, multiple leakages in
fluorescein angiography, and hyperlucent choroidal ves-
sels in indocyanine green angiography. The records of
these two cases were therefore reviewed in more detail.
Yellowish deposits were observed at the border of the
serous retinal detachment areas (Figure 5), and OCT
revealed hyper-reflective lesions between the RPE layer
and outer layer of the retina. FAF revealed ring-like
hyperautofluorescence around the serous retinal detach-
ment, which is rarely seen in chronic CSC (Figure 6).
This clinical appearance is seen in atypical VMD and
based on the EOGs of these patients, the first patient
had a decreased Arden ratio of 1.633 OD, 1.9 OS, and
the second patient had 1.266 OD and 1.173 OS
(Figure 7). For definite diagnosis, genetic examination was
conducted and both patients were VMD2 gene-positive,
and thus the diagnosis of VMD was confirmed.
Figure 3 Case 2 Case 2. A,B, Fundus photographs of both eyes showed atrophic lesion especillay near the macula, similar to case 1
patients. C,D, OCT findings of both eyes also showed serous retinal detachment.
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VMD is a rare disease with autosomal dominant inherit-
ance. It can occur in any age group, but when it is
detected in younger patients between 3 and 15 years of
age, it is considered to be a Best vitelliform macular dys-
trophy, and in patients ages between 30 and 50 years, it
is considered to be adult-onset VMD with differences in
the clinical appearance. It was recently discovered, how-
ever, that both are due to abnormalities of the Best1
gene with different phenotypes and its primary cause is
abnormalities in bestrophin function [8,9].
Typical fundus findings in VMD are egg yolk-like,
round or oval, lesions found in the bilateral macula. The
exact location of the deposits in the retina is unclear, but
based on spectral domain-OCT [17], they are located
beneath the sensory retina, causing changes in the
photoreceptor inner segment/outer segments. The cause
of the egg yolk-like yellowish deposits is unknown, but
may be due to unphagocytosed outer segments that ac-
cumulate because of the lack of apposition of the outer
membrane segments to the RPE. The persistence of the
material in the subretinal space increases the likelihood
of the formation of lipofuscin precursors, which areautofluorescent and susceptible to oxidative damage
[12]. In histologic examination, these lipofuscins appear
as egg yolk-like lesions [18]. In the advanced disease
state, lipofuscins normally get reabsorbed or disappear,
and cause atrophy in the RPE. The findings of fluores-
cein angiography vary based on the yellowish lesions,
usually hypofluorescence in the central lesions and a
window defect can be seen, and in FAF, the fluorescence
of the lesions is irregularly increased or decreased [19].
In EOG, a decrease in the Arden ratio is a distinctive
feature of VMD [14], due to a defect in Ca2+ activated
Cl- channels of the RPE basolateral membrane that
expresses bestrophin. Until recently, EOG has been the
most accurate test for determining the cause of the dis-
ease as well as genetic examination.
At a young age, bilateral neurosensory retinal detach-
ment can be caused by infections, inflammation,
collagen-vascular disease, tumor, age-related macular de-
generation, polypoidal choroidal vasculopathy, and CSC.
In the presented cases, there were no symptoms of in-
fection or inflammation, and both systemic disease and
tumor were also excluded. Age-related macular degener-
ation usually occurs at an advanced age, and polypoidal
Figure 4 A, Fluoresecein angiography findings of left eye revealed foveal hypofluorescene and surrounding hyperfluorescent ring.
B, Indocyanine green angiography showed moderated dilation of choroidal vessel. C,D, Fundus autofluorescence was increased at margin of
serous retinal detachment, and general reduction of autofluorescent due to serous exudates in both eyes.
Figure 5 A,B Case 1. Subretinal yellowish exudates with fluid level in the inferior part of serous retinal detachement are seen in
photography of both eyes. (arrows) B,C Case 2. There were little unclear, but yellowish exudates in inferior part of lesion were seen in both
eyes.
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Figure 6 Fundus autofluorescence (FAF) and spectral domain optical coherence tomography (SD-OCT) of case 1 patients. The yellowish
exudate lesion was seen hyperautofluorescent in FAF findings. SD-OCT revealed high reflectivity areas corresponding to subretinal exudates.
(arrow).
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polypoidal dilation was not observed on indocyanine
green angiography so it was excluded. Therefore, chronic
CSC was suspected based on the examinations and clin-
ical features in these cases.
Based on the clinical features, the patients were diag-
nosed with chronic CSC and received photodynamic
treatment for months. Case 1 received intravitreal beva-
cizumab injection and laser photocoagulation therapy to
coagulate the leaking points but serous retinal detach-
ment persisted for 2 years. Also, there was no change in
the autofluorescence for several years compared to the
baseline.
The common clinical features of the two cases led us
to review the patient records since the first visit. Al-
though both cases had a prolonged disease state, there
was no decrease in visual acuity, atrophic lesions in the
macula region were observed, fluorescein angiographyFigure 7 The electro-oculograms were abnormal with an Arden ratio
eyes, respectively.showed hypofluorescence in the macula, hyperfluores-
cence in the surrounding areas, and a window defect in
the surrounding region due to atrophy in the RPE layer.
Especially in FAF, both cases showed increased auto-
fluorescence in the border of serous retinal detachment,
and yellowish lesions were located below and around the
serous retinal detachment in the fundus photograph.
Spectral domain-OCT was used to scan the area and
showed hyper-reflective lesions between the RPE layer
and the photoreceptor IS/OS junction. We suspected
VMD in these two cases, because when VMD pro-
gresses, the yellowish egg yolk-like lesions in VMD get
absorbed spontaneously or form fluid, which can make
it difficult to find definite lesions, and we observed atro-
phic lesions of the macula and continuous subretinal
fluid. The source of the subretinal fluid appears to be
related to the underlying defect in VMD2, which
involves bestrophin, a Ca2+ -sensitive Cl– channelof 1.633, 1.9 (left, case 1) and 1.266, 1.173 (right, case 2) in both
Figure 8 The photoreceptor inner segment/outer segment junction was intact (arrow) which was confirmed by SD-OCT, even with RPE
atrophy after long standing serous retinal detachment.
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[12]. The EOG revealed a decrease in the Arden ratio in
both patients. Additionally, genetic examination revealed
the mutation in VMD2 gene, which led to a definite
diagnosis. The reasons why visual acuity was maintained
even after long-lasting VMD as follows were that the pa-
tient was comparably young, and photoreceptor inner
segment/outer segment junction was not disrupted,
which was confirmed by SD-OCT, even with RPE atro-
phy after long standing serous retinal detachment
(Figure 8).
In the case of CSC, as the disease state progresses
hyperautofluorescence or hypoautofluorescence can be
seen in FAF, but it is uncommon to find an overall de-
crease in autofluorescence in the center and an increase
in autofluorescence at the border of the serous retinal
detachment in CSC. Normally, egg yolk-like lesions in
VMD are lipofuscins, which can lead to an increase in
autofluorescence in the lesion areas. In these cases, the
autofluorescence decreased due to the absorption of
lesions in the central area and continuous serous retinal
detachment, and autofluorescence increased due to the
existence of deposits at the bottom border of the serous
retinal detachment and around the area of the serous
detachment. Especially in the second case, fundus pho-
tography and slit lamp examination revealed no yellow-
ish deposits, but FAF showed hyperautofluorescence in
the border of serous retinal detachment, so it was very
helpful for making a diagnosis.
Conclusions
In patients who do not respond to treatment for con-
tinuous bilateral serous retinal detachment, it is neces-
sary to differentiate atypical cases of VMD with careful
ophthalmologic examination. FAF may be helpful for
diagnosis.
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